Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug

Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug

Bibliographic Details
Main Authors:	Julia Lee, Sigmund Krajden, Christopher Graham, Andrea K. Boggild, Katerina Pavenski, Jay S. Keystone, Kevin C. Kain
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2015-01-01
Series:	Emerging Infectious Diseases
Subjects:	malaria artesunate artemisinin antimalarial hemolysis hemolytic anemia
Online Access:	https://wwwnc.cdc.gov/eid/article/21/1/14-0147_article

Similar Items

Post-Artesunate Delayed Hemolysis: A Review of Current Evidence
by: Sawettachai Jaita, et al.
Published: (2023-01-01)

Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France
by: Olivier Paccoud, et al.
Published: (2023-12-01)

Acute intravascular hemolysis in the critical phase of severe dengue
by: Sonali Ghosh, et al.
Published: (2021-01-01)

Malarial hepatopathy followed by delayed hemolysis after artemether–lumefantrine therapy for Plasmodium falciparum infection in a Colombian patient
by: Silvia J. Durán Sánchez, et al.
Published: (2023-09-01)

The current use of the artemisinin-based Combination Therapies in adult patients at a Tertiary Hospital, South-South Nigeria
by: STEPHEN AYINBUOMWAN, et al.
Published: (2022-12-01)

The current use of the artemisinin-based Combination Therapies in adult patients at a Tertiary Hospital, South-South Nigeria
by: STEPHEN AYINBUOMWAN, et al.
Published: (2022-12-01)

A case of asymptomatic pancytopenia with clinical features of hemolysis as a presentation of pernicious anemia
by: Venkateswara K. Kollipara, et al.
Published: (2016-09-01)

Malaria and safety issues associated with antimalarial drugs
by: A. S. Kazakov, et al.
Published: (2018-02-01)

Isolated hemolytic anemia: an unusual manifestation of occult malignancy
by: Matthew J. Butler, et al.
Published: (2014-02-01)

New approaches in antimalarial drug discovery and development: a review
by: Anna Caroline C Aguiar, et al.
Published: (2012-11-01)

Hemolysis by Saponin Is Accelerated at Hypertonic Conditions
by: Boyana Paarvanova, et al.
Published: (2023-10-01)

Imported severe Plasmodium falciparum infection in the first trimester of pregnancy complicated by post-artemisinin delayed hemolysis and intrauterine fetal death, a case report
by: Kohei Kamegai, et al.
Published: (2023-05-01)

Impact of antimalarial resistance and COVID-19 pandemic on malaria care among pregnant women in Northern Uganda (ERASE): protocol of a prospective observational study
by: Francesco Vladimiro Segala, et al.
Published: (2022-08-01)

Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
by: Richard M. Hoglund, et al.
Published: (2018-09-01)

Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations
by: Oliver M, et al.
Published: (2023-12-01)

Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature
by: Olivier Boillat, et al.
Published: (2015-11-01)

Clinical Pharmacology of the Antimalarial Artemisinin-Based Combination and other Artemisinins in Children
by: Gian Maria Pacifici
Published: (2018-07-01)

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
by: Qi Jin, et al.
Published: (2023-02-01)

Hemolysis and COVID-19 infection: A fatal combination – An interesting series of three cases
by: K. V. Vinu Balraam, et al.
Published: (2022-01-01)

Putative molecular markers of Plasmodium falciparum resistance to antimalarial drugs in malaria parasites from Ghana
by: Sena Adzoa Matrevi, et al.
Published: (2024-02-01)

Age-dependent antibody profiles to plasmodium antigens are differentially associated with two artemisinin combination therapy outcomes in high transmission setting
by: Ben Andagalu, et al.
Published: (2022-10-01)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
by: Rosemonde M. Guissou, et al.
Published: (2023-09-01)

MMV006087 is a potent Malaria Box compound against Plasmodium falciparum clinical parasites
by: Jersley D. Chirawurah, et al.
Published: (2023-06-01)

Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum
by: Tanyaluck Kampoun, et al.
Published: (2023-04-01)

Discovery of new targets for antimalarial chemotherapy
by: Grellier P., et al.
Published: (2008-09-01)

Stem cell therapy for dogs with immune-mediated hemolytic anemia
by: Yeonmi Lee, et al.
Published: (2024-03-01)

Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature
by: Hans Benno Leicht, et al.
Published: (2018-10-01)

Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia
by: Fitri LE, et al.
Published: (2023-07-01)

LC-MS/TOF Characterization and Stability Study of Artesunate in Different Solvent Systems
by: Kogila Oke, et al.
Published: (2022-08-01)

Photoaffinity probe‐based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum
by: Peng Gao, et al.
Published: (2024-04-01)

Tratamento da malária com artesunate (retocaps®) em crianças da Amazônia brasileira Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon
by: Maria das Graças Costa Alecrim, et al.
Published: (2000-04-01)

Estimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach
by: Ellen K. G. Mhango, et al.
Published: (2023-03-01)

Antimalarial natural products: a review
by: Faraz Mojab
Published: (2012-03-01)

The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage <i>P. falciparum</i> Parasites, DMPK Properties, and the Case for Artemiside
by: Liezl Gibhard, et al.
Published: (2021-12-01)

The Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report
by: Duong Le Xuan, et al.
Published: (2023-10-01)

A thorny matter: Spur cell anemia
by: Ruchi Sharma, et al.
Published: (2023-01-01)

COMPLEMENTARY FINDINGS ON THE ANTIMALARIAL ACTIVITY AND TOXICITY OF METHYLENE BLUE.
by: Giovanny GARAVITO, et al.
Published: (2009-02-01)

Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving Alectinib
by: Julia Kunz, et al.
Published: (2022-05-01)

Artemisinins induce endoplasmic reticulum stress in acute leukaemia cells in vitro and in vivo
by: Rubia Isler Mancuso, et al.
Published: (2021-11-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
by: Mahamat Souleymane Issa, et al.
Published: (2023-08-01)